Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MOH
BUYFLAGMolina Healthcare, Inc. · Healthcare · United States · $10.3B · Avg Vol: $293M/d
Molina Healthcare has strong momentum at M74 with a buyback on file, but quality Q51 and value V52 both miss the all-three-above-60 path, and insiders sold 0.04% with no offsetting purchase, which is separately adverse.
COMPANY DESCRIPTION
Molina Healthcare, Inc. provides managed healthcare services exclusively to government-sponsored programs, primarily Medicaid and Medicare, across the United States. Its deep expertise in navigating complex regulatory environments and delivering integrated care to underserved populations offers a significant competitive advantage. Molina is a prominent, mission-driven participant in the government healthcare market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.0B | 34.1B | 40.6B | 45.4B | 12.4% | 43.1B | 44.4B | 48.1B | 2.9% |
| EPS | 13.66 | 18.71 | 21.05 | 9.18 | -12.4% | 3.81 | 5.21 | 8.55 | -3.5% |
| Shares | 58.0M | 58.3M | 56.0M | 51.4M | -11.4% | 52.1M | — | — | — |
| Debt | 2.4B | 2.4B | 3.1B | 4.0B | 18.2% | 3.9B | — | — | — |
| Equity | 3.0B | 4.2B | 4.5B | 4.1B | 11.1% | — | — | — | — |
| Op CF | 773.0M | 1.7B | 644.0M | -535.0M | -8.7% | 357.0M | — | — | — |
| Inv CF | -790.0M | -744.0M | -464.0M | 312.0M | — | — | — | — | — |
| Fin CF | -441.0M | -58.0M | -347.0M | -170.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MOH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MOH | Molina Healthcare, Inc.(you) | $10.3B | 77 | BUY |
| OSCR | Oscar Health, Inc. | $8.5B | 88 | STRONG BUY |
| HUM.MX | Humana Inc. | $24.1B | 83 | STRONG BUY |
| CLOV | Clover Health Investments, Corp. | $2.3B | 73 | BUY |
| CNC | Centene Corporation | $31.3B | 92 | STRONG BUY |
| ALHC | Alignment Healthcare, Inc. | $4.0B | 53 | HOLD |
| PGNY | Progyny, Inc. | $2.4B | 97 | STRONG BUY |
| ELV | Elevance Health, Inc. | $81.9B | 94 | STRONG BUY |
| CI | The Cigna Group | $76.6B | 97 | STRONG BUY |
| CVS | CVS Health Corporation | $137.5B | 90 | STRONG BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.7%